´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸ : 2019-05-17±³À°ÀÏÀÚ : 2019-05-17
±³À°Àå¼Ò : ºÎ»ê·Ôµ¥È£ÅÚ Å©¸®½ºÅ»º¼·ë(3Ãþ)
±³À°ÁÖÁ¦ :
´ëÇѼҾƽŰæÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇѼҾƽŰæÇÐȸ
´ã´çÀÚ : ±è¼¼Èñ
¿¬¶ôó : 02-2228-2050
À̸ÞÀÏ :
seheekim@yuhs.ac ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 7 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-17 Á¦1°ÀÇ½Ç 08:00~08:20 Neurofibromatosis ÃÖ¼±¾Æ(´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦1°ÀÇ½Ç 08:20~08:40 Tuberous sclerosis complex and related syndromes ¹Ú¼Ò¿µ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦1°ÀÇ½Ç 08:40~09:00 Sturge-weber syndrome À¯¸®Å¸(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦1°ÀÇ½Ç 09:00~09:30 Diagnostic flow for rare neurologic disorders äÁ¾Èñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦1°ÀÇ½Ç 09:30~10:00 Value of diagnostic exome sequencing and aCGH ±è¼¼Èñ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦1°ÀÇ½Ç 10:00~10:30 Applications of AI in rare neurologic diseases ȲÈñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦1°ÀÇ½Ç 10:30~11:00 Medical treatment for neurogenetic or neurometabolic disorders Ȳ¼ö°æ(°æºÏÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦1°ÀÇ½Ç 11:00~11:30 Update of gene therapy for neuromuscular disorders ÀÌÇÏ´Ã(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦2°ÀÇ½Ç 08:00~08:20 Treatable or self-limiting pediatric movement disorders ³ëº´È£(°¿øÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦2°ÀÇ½Ç 08:20~08:40 Treatment of multiple sclerosis in the ideal and real world Á¶¾È³ª(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦2°ÀÇ½Ç 08:40~09:00 Treatable or observable sleep disorders in children ±è½Â¼ö(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦2°ÀÇ½Ç 09:00~09:30 What can we do for super-refractory status epilepticus? ÀÌÁöÈÆ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦2°ÀÇ½Ç 09:30~10:00 Cannabidiol for drug-resistant epilepsy ÀÌâ¿ì(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦2°ÀÇ½Ç 10:00~10:30 Unusual refractory headaches in adolescents ÀÌ°ÇÈñ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦2°ÀÇ½Ç 10:30~11:00 Spasticity treatment and mangement in cerebral palsy ³ªµ¿¿í(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-17 Á¦2°ÀÇ½Ç 11:00~11:30 Best treatment for transverse myelitis and CIDP ±è½ÅÇý(¸íÁöº´¿ø)